Huizing et al. Page 20 [127]. Martin RA, Slaugh R, Natowicz M, Pearlman K, Orvisky E, Krasnewich D, Kleta R, Huizing A M, Gahl WA, Sialic acid storage disease of the Salla phenotype in American monozygous twin uthor Man female sibs, Am J Med Genet A 120A (2003) 23–27. [PubMed: 12794687] [128]. Bardor M, Nguyen DH, Diaz S, Varki A, Mechanism of uptake and incorporation of the non- human sialic acid N-glycolylneuraminic acid into human cells, J Biol Chem 280 (2005) 4228– 4237. [PubMed: 15557321] uscr [129]. Ng BG, Asteggiano CG, Kircher M, Buckingham KJ, Raymond K, Nickerson DA, Shendure J, Bamshad MJ, University G of Washington Center for Mendelian, M. Ensslen, H.H. Freeze, ipt Encephalopathy caused by novel mutations in the CMP-sialic acid transporter, SLC35A1, Am J Med Genet A 173 (2017) 2906–2911. [PubMed: 28856833] [130]. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P, The human sialyltransferase family, Biochimie 83 (2001) 727–737. [PubMed: 11530204] [131]. Eisenberg I, Avidan N, Potikha T, Hochner H, Chen M, Olender T, Barash M, Shemesh M, Sadeh M, Grabov-Nardini G, Shmilevich I, Friedmann A, Karpati G, Bradley WG, Baumbach L, Lancet D, Asher EB, Beckmann JS, Argov Z, Mitrani-Rosenbaum S, The UDP-N- acetylglucosamine 2-epimerase/N-acetylmannosamine kinase gene is mutated in recessive A uthor Man hereditary inclusion body myopathy, Nat Genet 29 (2001) 83–87. [PubMed: 11528398] [132]. d’Azzo A, Machado E, Annunziata I, Pathogenesis, Emerging therapeutic targets and Treatment in Sialidosis, Expert Opin Orphan Drugs 3 (2015) 491–504. [PubMed: 26949572] uscr ipt A uthor Man uscr ipt A uthor Man uscr ipt Neurosci Lett. Author manuscript; available in PMC 2021 June 11.